136 related articles for article (PubMed ID: 32650347)
1. Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose.
Wronska E; Polkowski M; Orlowska J; Mroz A; Wieszczy P; Regula J
Endoscopy; 2021 Feb; 53(2):123-132. PubMed ID: 32650347
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.
Bright T; Watson DI; Tam W; Game PA; Ackroyd R; Devitt PG; Schoeman MN
Dig Dis Sci; 2009 Dec; 54(12):2606-11. PubMed ID: 19101798
[TBL] [Abstract][Full Text] [Related]
4. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
[TBL] [Abstract][Full Text] [Related]
5. Argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus: late outcomes from two randomized trials.
Sie C; Bright T; Schoeman M; Game P; Tam W; Devitt P; Watson D
Endoscopy; 2013 Nov; 45(11):859-65. PubMed ID: 24019134
[TBL] [Abstract][Full Text] [Related]
6. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus.
Dulai GS; Jensen DM; Cortina G; Fontana L; Ippoliti A
Gastrointest Endosc; 2005 Feb; 61(2):232-40. PubMed ID: 15729231
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.
Sharma P; Wani S; Weston AP; Bansal A; Hall M; Mathur S; Prasad A; Sampliner RE
Gut; 2006 Sep; 55(9):1233-9. PubMed ID: 16905695
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE).
Peerally MF; Bhandari P; Ragunath K; Barr H; Stokes C; Haidry R; Lovat L; Smart H; Harrison R; Smith K; Morris T; de Caestecker JS
Gastrointest Endosc; 2019 Apr; 89(4):680-689. PubMed ID: 30076843
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery.
Ackroyd R; Tam W; Schoeman M; Devitt PG; Watson DI
Gastrointest Endosc; 2004 Jan; 59(1):1-7. PubMed ID: 14722539
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium.
Basu KK; Pick B; Bale R; West KP; de Caestecker JS
Gut; 2002 Dec; 51(6):776-80. PubMed ID: 12427775
[TBL] [Abstract][Full Text] [Related]
13. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
Gossner L; May A; Stolte M; Seitz G; Hahn EG; Ell C
Gastrointest Endosc; 1999 Jan; 49(1):8-12. PubMed ID: 9869716
[TBL] [Abstract][Full Text] [Related]
14. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
[TBL] [Abstract][Full Text] [Related]
15. Improving clinical outcomes of Barrett's esophagus with high dose proton pump inhibitors and cryoablation.
Snady H
Ann Med; 2023 Dec; 55(1):1256-1264. PubMed ID: 37232568
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.
Van Laethem JL; Cremer M; Peny MO; Delhaye M; Devière J
Gut; 1998 Dec; 43(6):747-51. PubMed ID: 9824599
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study.
Pedrazzani C; Catalano F; Festini M; Zerman G; Tomezzoli A; Ruzzenente A; Guglielmi A; de Manzoni G
World J Gastroenterol; 2005 Mar; 11(12):1872-5. PubMed ID: 15793884
[TBL] [Abstract][Full Text] [Related]
20. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
